Private Practice for Gastroenterology
- Address
- Bergheimerstrasse 59-61, 69115 Heidelberg, Germany
Private Practice for Gastroenterology
This specialized gastroenterology practice focuses on advancing treatment options for patients with inflammatory bowel diseases, with particular expertise in managing chronic intestinal conditions. The center is dedicated to evaluating novel therapeutic approaches that address both symptomatic relief and underlying disease mechanisms.
- Ulcerative colitis treatment and management
- Endoscopic assessment and monitoring of inflammatory bowel disease
- Novel oral delivery systems for targeted intestinal therapy
The practice participates in clinical research evaluating innovative treatments for mild to moderately active ulcerative colitis, including investigations of controlled-release formulations designed to optimize drug delivery to affected areas of the colon. Their research encompasses comprehensive outcome measures including symptomatic remission, endoscopic response, and histologic improvement, with both short-term and long-term follow-up protocols to assess sustained clinical benefits for patients with inflammatory bowel conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Cinclus Pharma Holding AB (publ)2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Private Practice for Gastroenterology
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of Linaprazan Glurate versus Lansoprazole for Maintenance of Healing in Patients with Healed Erosive Esophagitis Due to Gastroesophageal Reflux Disease | Cinclus Pharma Holding AB (publ) | Phase III | Not Recruiting | — | May 2026 |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Lansoprazole | 2 | Unknown | 2025-10-03 | 2025-10-03 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.